Grant: Project Grant
McGill University
$910,350.00
AI & Personalized Therapeutics
EF 2022-23
Résumé
Prescription drugs play an expanding and essential role in preventing and treating chronic health problems. However, medications are currently not as beneficial as they could be. This is due to little information on their safety and effectiveness after approval for sale. It is also difficult to personalize treatment to a particular patient and to guide physicians when prescribing medications. Personalizing treatment is important because patients with the same medical conditions do not always benefit equally from the same medications. Patients' experiences often differ based on demographic, genetic, and clinical factors. A patient of a certain age, sex, genetic profile, and medical history may benefit from a medication that harms a patient with different traits. Many factors that affect response to therapy are known, but even more are not. It can also be difficult for physicians to account for every factor when prescribing medications. Our research team proposes the following:
1.To use a wealth of information from hospital, pharmacy, and provincial sources to develop predictive algorithms to personalize therapy. Our algorithms will identify factors that affect patient response to treatment and will predict, for a single patient, the risks and benefits of using different medications.
2.To develop computer-based tools that use these algorithms and help physicians make decisions when prescribing medications.
3.To conduct clinical trials to find out if these tools improve treatment and patients' health.
Programme
Project Grant
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
468682
Name
Tamblyn Robyn M
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Population and Public Health
Theme2
Clinical
Prcname2
Public, Community & Population Health
Projecttitle
AI & Personalized Therapeutics
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$910,350
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Artificial Intelligence; Big Data; Machine Learning; Patient-Reported Outcomes; Personalized Medicine; Pharmacare; Pragmatic Trials; Predictive Analytics; Reinforcement Learning
Abstract
Prescription drugs play an expanding and essential role in preventing and treating chronic health problems. However, medications are currently not as beneficial as they could be. This is due to little information on their safety and effectiveness after approval for sale. It is also difficult to personalize treatment to a particular patient and to guide physicians when prescribing medications. Personalizing treatment is important because patients with the same medical conditions do not always benefit equally from the same medications. Patients' experiences often differ based on demographic, genetic, and clinical factors. A patient of a certain age, sex, genetic profile, and medical history may benefit from a medication that harms a patient with different traits. Many factors that affect response to therapy are known, but even more are not. It can also be difficult for physicians to account for every factor when prescribing medications. Our research team proposes the following:
1.To use a wealth of information from hospital, pharmacy, and provincial sources to develop predictive algorithms to personalize therapy. Our algorithms will identify factors that affect patient response to treatment and will predict, for a single patient, the risks and benefits of using different medications.
2.To develop computer-based tools that use these algorithms and help physicians make decisions when prescribing medications.
3.To conduct clinical trials to find out if these tools improve treatment and patients' health.
Competitiondate
202209
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Tamblyn, Robyn M; Filion, Kristian B; McDonald, Emily G; Singer, Wendy
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $910,350~ $0~